| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10620-016-4383-Z |
| P698 | PubMed publication ID | 27885460 |
| P50 | author | Andrew M Kaunitz | Q96619638 |
| Rebecca Allen | Q60055446 | ||
| P2093 | author name string | Aparna Sridhar | |
| Carrie A Cwiak | |||
| P2860 | cites work | European evidence based consensus on the diagnosis and management of Crohn's disease: special situations | Q22242050 |
| Effectiveness of Long-Acting Reversible Contraception | Q22250875 | ||
| Combined oral contraceptives: venous thrombosis | Q24198113 | ||
| Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis | Q24622035 | ||
| Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects | Q28219103 | ||
| The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results. | Q33390023 | ||
| Limited knowledge on progestogen-only contraception and risk of venous thromboembolism | Q33403219 | ||
| U S. Medical Eligibility Criteria for Contraceptive Use, 2010. | Q34121468 | ||
| Meeting the need for women's health training in gastroenterology: creation of a women's digestive disorders program at Brown University | Q34132275 | ||
| Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women | Q34135348 | ||
| U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition | Q34352129 | ||
| Recovery of menstruation and pregnancy after liver transplantation | Q34391563 | ||
| Pregnancy and liver disease | Q34493971 | ||
| Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action | Q34631984 | ||
| Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis | Q34977130 | ||
| Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study | Q35356341 | ||
| Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation | Q36155827 | ||
| Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period | Q84513590 | ||
| Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases | Q84831815 | ||
| Pregnancy after liver transplantation | Q85640296 | ||
| Injectable contraception: issues and opportunities | Q87755494 | ||
| Contraceptive use in female recipients of a solid-organ transplant | Q36848191 | ||
| Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study | Q37055712 | ||
| The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review | Q37596664 | ||
| Three-year continuation of reversible contraception. | Q37624835 | ||
| Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review | Q37676787 | ||
| Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases | Q37701045 | ||
| Contraceptive use among women with inflammatory bowel disease: A systematic review | Q37777447 | ||
| Contraceptive use among solid organ transplant patients: a systematic review | Q37777450 | ||
| Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease | Q37847627 | ||
| Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women | Q37873544 | ||
| Update on hormonal contraception and bone density | Q37874152 | ||
| Special considerations for women with IBD. | Q37878102 | ||
| Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review | Q37981407 | ||
| Risk of venous thromboembolism in patients with inflammatory bowel disease. | Q38102941 | ||
| Family planning and inflammatory bowel disease: the patient and the practitioner | Q39578016 | ||
| Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. | Q40014780 | ||
| Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population | Q40341602 | ||
| Effect of oral contraceptive use on reoperation following surgery for Crohn's disease | Q41108821 | ||
| Current contraceptive status among women aged 15-44: United States, 2011-2013. | Q41698805 | ||
| Contraception and fertility awareness among women with solid organ transplants | Q41734340 | ||
| The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device | Q42924611 | ||
| Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial | Q42928363 | ||
| Contraceptive awareness and birth control selection in female kidney and liver transplant recipients | Q43415683 | ||
| Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture. | Q44140815 | ||
| Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study | Q44355973 | ||
| Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study | Q45061360 | ||
| Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes | Q45091263 | ||
| The levonorgestrel-releasing intrauterine system in human immunodeficiency virus-infected women: a 5-year follow-up study | Q45371589 | ||
| Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California | Q46604800 | ||
| Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study | Q47622471 | ||
| Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. | Q50883754 | ||
| Low-dose hormonal contraception after liver transplantation. | Q51469244 | ||
| A comparison between the vaginal ring and oral contraceptives. | Q51625000 | ||
| Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant. | Q53204795 | ||
| Shifts in intended and unintended pregnancies in the United States, 2001-2008. | Q54417497 | ||
| Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries | Q57301130 | ||
| Inflammatory Bowel Disease Has a Small Effect on Bone Mineral Density and Risk for Osteoporosis | Q57711420 | ||
| Normalization of menstrual pattern after liver transplantation: consequences for contraception | Q68669767 | ||
| Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy | Q69942568 | ||
| The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy | Q70280192 | ||
| Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascul | Q74798778 | ||
| Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive | Q80050371 | ||
| Liver disease in pregnancy | Q82917649 | ||
| Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV | Q84421705 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 54-63 | |
| P577 | publication date | 2016-11-24 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Contraceptive Considerations for Women with Gastrointestinal Disorders | |
| P478 | volume | 62 |
Search more.